VIVOBIOTBSEVIVO BIO TECH LTD.LowNeutral
Announced Wed, 30 Sept, 2026 · 18:57 IST

Vivo Bio Tech 39th AGM outcome: 4 items passed, directors re-appointed

Board & Shareholder Meetings View source PDFExplain this filing

VIVOBIOT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-15.0%1-day move
₹17.17
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-15.0-19.6-9.8-16.1——————
Up moveDown movePending
AI summary

Vivo Bio Tech held its 39th AGM on September 30, 2026 via video conferencing with 67 members present. All 4 items of business were transacted, including adoption of audited financial statements for FY ended March 31, 2026 and re-appointment of Mr. Sri Kalyan Kompella and Dr. Sankaranarayanan Alangudi as Whole-time Directors for five-year terms. Mr. Kalyan Ram Mangipudi was also re-appointed by rotation. Auditors report had no qualifications. Voting results to be disclosed by October 3, 2026.

Likely market impact

Routine AGM proceedings completed cleanly with no audit qualifications. Re-appointments provide management stability for the next five years.